Antitrust & Competition Life Sciences Quarterly Update Q3 2023
The third quarter in the life sciences space saw notable developments in significant agency enforcement actions: The FTC abandoned its pursuit of a novel theory and settled its Amgen/Horizon lawsuit...
Source: marketscreener.com